Skip to content

ARENA PHARMACEUTICALS INC

Delisted

CIK 1080709fmd_1F6J6YYB9728B683AYHWC6D5N4Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Dec 31, 2021, 49 periods

Latest annual · FY2021

Millions
Total revenues
0
Gross profit
83
Operating income
(624)
Net income
(616)
Free cash flow
(453)

Latest quarter · Q4 FY2021

Millions
Total revenues
0
Operating income
(153)
Net income
(156)
Free cash flow
(121)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
-85.6%
Revenue, 5 yearsFY2016 to FY2021
-77.4%
Net income, 5 yearsFY2016 to FY2021
n/m

ARENA PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$54,000$319,000-83.1%10-K 2022-02-23 · proof
Operating income-$624.3 million-$426.6 million10-K 2022-02-23 · proof
Net income-$616.4 million-$404.7 million10-K 2022-02-23 · proof
Cash from operating activities-$452 million-$353.1 million10-K 2022-02-23 · proof
Free cash flow-$453 million-$353.9 million10-K 2022-02-23 · proof
Total assets$784.7 million$1.2 billion-34.1%10-K 2022-02-23 · proof
Total liabilities$111.5 million$110.3 million+1.1%10-K 2022-02-23 · proof
Cash and cash equivalents$224.6 million$219.5 million+2.3%10-K 2022-02-23 · proof
What was ARENA PHARMACEUTICALS INC's revenue in fiscal 2021?
ARENA PHARMACEUTICALS INC reported revenue of $54,000 for fiscal 2021 (the year ended Dec 31, 2021), against $319,000 the year before (-83.1%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was ARENA PHARMACEUTICALS INC's operating income in fiscal 2021?
ARENA PHARMACEUTICALS INC reported operating income of -$624.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$426.6 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was ARENA PHARMACEUTICALS INC's net income in fiscal 2021?
ARENA PHARMACEUTICALS INC reported net income of -$616.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$404.7 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was ARENA PHARMACEUTICALS INC's cash from operating activities in fiscal 2021?
ARENA PHARMACEUTICALS INC reported cash from operating activities of -$452 million for fiscal 2021 (the year ended Dec 31, 2021), against -$353.1 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was ARENA PHARMACEUTICALS INC's free cash flow in fiscal 2021?
ARENA PHARMACEUTICALS INC reported free cash flow of -$453 million for fiscal 2021 (the year ended Dec 31, 2021), against -$353.9 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are ARENA PHARMACEUTICALS INC's total assets?
As of Dec 31, 2021, ARENA PHARMACEUTICALS INC reported total assets of $784.7 million, against $1.2 billion a year earlier (-34.1%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are ARENA PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2021, ARENA PHARMACEUTICALS INC reported total liabilities of $111.5 million, against $110.3 million a year earlier (+1.1%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are ARENA PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2021, ARENA PHARMACEUTICALS INC reported cash and cash equivalents of $224.6 million, against $219.5 million a year earlier (+2.3%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1080709&period_type=annual&limit=5"

Information only, not investment advice.